Related Experiment Videos
Fragile X syndrome, the Fragile X related proteins, and animal models
André T Hoogeveen1, Rob Willemsen, Ben A Oostra
1Department of Clinical Genetics, Erasmus University, 3000 DR Rotterdam, The Netherlands. Hoogeveen@ikg.fgg.eur.nl
Abstract:
The Fragile X syndrome (FraX), which is characterized among other physical and neurologic impairments by mental retardation, is caused by the absence of the product of the FMR1 gene. The Fragile X Mental Retardation Protein (FMRP) is a member of a novel family of RNA-binding proteins. The latter includes two other proteins highly homologous with FMRP: the fragile X related proteins 1 and 2 (FXRP1 and FXRP2). Characterization of FXRPs, including their interaction with FMRP, will provide critical information about the mechanisms of action of FMRP and the role of this group of proteins in FMRP-deficient conditions such as FraX. Genetic manipulations of FMRP and the FXRPs should also provide valuable tools for investigating pathophysiology and gene therapies in FraX. The present review summarizes the strategies used for identifying the FXRPs, their chromosomal localization, molecular structure, and tissue distribution. It also reviews interactions between different members of this family of RNA-binding proteins. Animal models, both knockout and transgenic, of FMRP and the FXRPs are discussed. Phenotypic features of the FMR1 knockout mouse, the FMR1 transgenic rescue mouse, and other novel strategies for manipulating and delivering FMRP and FXRPs to the brain and other tissues are described.
Insights
Fragile X syndrome (FraX) stems from the lack of Fragile X Mental Retardation Protein (FMRP). Researchers are studying related proteins (FXRPs) and animal models to understand FraX mechanisms and develop gene therapies.
Area of Science:
- Neurogenetics
- Molecular Biology
- Developmental Disorders
Background:
- Fragile X syndrome (FraX) is a genetic disorder causing intellectual disability due to FMR1 gene mutations.
- The Fragile X Mental Retardation Protein (FMRP) is crucial for normal neurological development.
- FMRP belongs to a family of RNA-binding proteins, including FXRP1 and FXRP2, which are highly homologous.
Purpose of the Study:
- To characterize fragile X related proteins (FXRPs) and their interactions with FMRP.
- To elucidate the role of the FMRP protein family in FMRP-deficient conditions like FraX.
- To explore potential gene therapies for FraX using genetic manipulation strategies.
Main Methods:
- Review of strategies for identifying FXRPs.
- Analysis of chromosomal localization, molecular structure, and tissue distribution of FXRPs.
- Discussion of animal models (knockout and transgenic) for FMRP and FXRPs.
Main Results:
- Identification and characterization of FXRP1 and FXRP2 as homologous proteins to FMRP.
- Insights into the interactions between FMRP and FXRPs.
- Description of phenotypic features in FMR1 knockout and transgenic mouse models.
Conclusions:
- Understanding FXRPs is critical for elucidating FMRP's function and FraX pathophysiology.
- Genetic manipulation of FMRP and FXRPs offers promising avenues for FraX research and therapeutic development.
- Animal models are essential tools for studying FraX mechanisms and evaluating gene delivery strategies.